Dr. Carson Discusses Mogamulizumab as Potential Treatment for CTCL
9 Görünümler
• 08/09/23
0
0
gömmek
administrator
Aboneler
Kenneth R. Carson, MD, assistant professor, Division of Oncology, Washington University, discusses mogamulizumab as a potential treatment for patients with relapsed or refractory cutaneous T cell lymphoma (CTCL).
Daha fazla göster
Facebook Yorumları
SORT BY-
En Çok Yorumlananlar
-
Son Yorumlar